pubmed-article:11336187 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:11336187 | lifeskim:mentions | umls-concept:C0020538 | lld:lifeskim |
pubmed-article:11336187 | lifeskim:mentions | umls-concept:C0028128 | lld:lifeskim |
pubmed-article:11336187 | lifeskim:mentions | umls-concept:C0011710 | lld:lifeskim |
pubmed-article:11336187 | lifeskim:mentions | umls-concept:C0037494 | lld:lifeskim |
pubmed-article:11336187 | lifeskim:mentions | umls-concept:C0813203 | lld:lifeskim |
pubmed-article:11336187 | lifeskim:mentions | umls-concept:C0205216 | lld:lifeskim |
pubmed-article:11336187 | lifeskim:mentions | umls-concept:C0000975 | lld:lifeskim |
pubmed-article:11336187 | pubmed:issue | 4 Pt 1 | lld:pubmed |
pubmed-article:11336187 | pubmed:dateCreated | 2001-5-4 | lld:pubmed |
pubmed-article:11336187 | pubmed:abstractText | The response to exogenous administration of acetylcholine and the effects of nitric oxide (NO) synthesis blockade were assessed for small arterioles in the cremaster muscle of deoxycorticosterone acetate (DOCA)-salt hypertensive and normotensive rats using intravital microscopy. The NO synthesis inhibitor N omega-L-nitro-arginine methyl ester (L-NAME) produced significantly less constriction in the arterioles of DOCA-salt hypertensive rats. Exposure to increasing concentrations of acetylcholine (10(-10) to 10(-5) mol/L) or sodium nitroprusside (10(-10) to 10(-5) mol/L) produced similar arteriolar dilation in both groups. These results suggest that attenuated basal release of NO by arterioles may play a role in the development of increased peripheral resistance observed in DOCA-salt hypertension. | lld:pubmed |
pubmed-article:11336187 | pubmed:language | eng | lld:pubmed |
pubmed-article:11336187 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11336187 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:11336187 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11336187 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11336187 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11336187 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11336187 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11336187 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11336187 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11336187 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11336187 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11336187 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11336187 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:11336187 | pubmed:month | Apr | lld:pubmed |
pubmed-article:11336187 | pubmed:issn | 0895-7061 | lld:pubmed |
pubmed-article:11336187 | pubmed:author | pubmed-author:JoshuaI GIG | lld:pubmed |
pubmed-article:11336187 | pubmed:author | pubmed-author:Ayangade-John... | lld:pubmed |
pubmed-article:11336187 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:11336187 | pubmed:volume | 14 | lld:pubmed |
pubmed-article:11336187 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:11336187 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:11336187 | pubmed:pagination | 387-9 | lld:pubmed |
pubmed-article:11336187 | pubmed:dateRevised | 2009-2-24 | lld:pubmed |
pubmed-article:11336187 | pubmed:meshHeading | pubmed-meshheading:11336187... | lld:pubmed |
pubmed-article:11336187 | pubmed:meshHeading | pubmed-meshheading:11336187... | lld:pubmed |
pubmed-article:11336187 | pubmed:meshHeading | pubmed-meshheading:11336187... | lld:pubmed |
pubmed-article:11336187 | pubmed:meshHeading | pubmed-meshheading:11336187... | lld:pubmed |
pubmed-article:11336187 | pubmed:meshHeading | pubmed-meshheading:11336187... | lld:pubmed |
pubmed-article:11336187 | pubmed:meshHeading | pubmed-meshheading:11336187... | lld:pubmed |
pubmed-article:11336187 | pubmed:meshHeading | pubmed-meshheading:11336187... | lld:pubmed |
pubmed-article:11336187 | pubmed:meshHeading | pubmed-meshheading:11336187... | lld:pubmed |
pubmed-article:11336187 | pubmed:meshHeading | pubmed-meshheading:11336187... | lld:pubmed |
pubmed-article:11336187 | pubmed:meshHeading | pubmed-meshheading:11336187... | lld:pubmed |
pubmed-article:11336187 | pubmed:meshHeading | pubmed-meshheading:11336187... | lld:pubmed |
pubmed-article:11336187 | pubmed:meshHeading | pubmed-meshheading:11336187... | lld:pubmed |
pubmed-article:11336187 | pubmed:meshHeading | pubmed-meshheading:11336187... | lld:pubmed |
pubmed-article:11336187 | pubmed:meshHeading | pubmed-meshheading:11336187... | lld:pubmed |
pubmed-article:11336187 | pubmed:meshHeading | pubmed-meshheading:11336187... | lld:pubmed |
pubmed-article:11336187 | pubmed:meshHeading | pubmed-meshheading:11336187... | lld:pubmed |
pubmed-article:11336187 | pubmed:meshHeading | pubmed-meshheading:11336187... | lld:pubmed |
pubmed-article:11336187 | pubmed:meshHeading | pubmed-meshheading:11336187... | lld:pubmed |
pubmed-article:11336187 | pubmed:meshHeading | pubmed-meshheading:11336187... | lld:pubmed |
pubmed-article:11336187 | pubmed:year | 2001 | lld:pubmed |
pubmed-article:11336187 | pubmed:articleTitle | Decreased influence of nitric oxide on deoxycorticosterone acetate (DOCA)-salt hypertension. | lld:pubmed |
pubmed-article:11336187 | pubmed:affiliation | Department of Pediatrics, University of Louisville School of Medicine, Kentucky, USA. | lld:pubmed |
pubmed-article:11336187 | pubmed:publicationType | Journal Article | lld:pubmed |